Mangga, Baby Boy .
HRN: 21-83-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
08/24/2022
08/31/2022
IV
15mg
Q24h
Potential Septic Newborn (prom X 25hours)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes